although
case
chronic
obstruct
pulmonari
diseas
copd
occur
smoker
fraction
smoker
develop
diseas
hypothes
distinct
molecular
signatur
copd
emphysema
peripher
blood
mononuclear
cell
pbmc
current
former
smoker
test
hypothesi
identifi
valid
pbmc
gene
express
profil
smoker
without
copd
gener
express
data
subject
copdgen
studi
use
affymetrix
microarray
affymetrix
santa
clara
ca
multipl
linear
regress
adjust
covari
gender
age
bodi
mass
index
famili
histori
smoke
statu
packyear
use
identifi
candid
gene
ingenu
pathway
analysi
use
identifi
candid
pathway
candid
gene
valid
subject
accord
multiplex
quantit
realtim
polymeras
chain
reaction
includ
subject
previous
profil
pathway
differenti
express
subject
copd
emphysema
includ
play
role
immun
system
inflammatori
respons
sphingolipid
ceramid
metabol
twentysix
candid
gene
eg
valid
independ
cohort
plasma
metabolom
use
identifi
novel
glycoceramid
galabiosylceramid
biomark
emphysema
support
genom
associ
acid
ceramidas
emphysema
copd
system
diseas
whose
gene
express
signatur
pbmc
could
serv
novel
diagnost
therapeut
target
chronic
obstruct
pulmonari
diseas
copd
result
combin
environment
exposur
genet
suscept
third
lead
caus
death
unit
state
although
cigarett
smoke
major
environment
risk
factor
present
greater
patient
copd
approxim
smoker
develop
copd
previou
studi
shown
herit
risk
factor
relationship
genet
risk
molecular
chang
associ
copd
remain
unknown
although
tradit
definit
copd
base
spirometri
measur
recent
work
suggest
distinct
copd
subtyp
independ
spirometri
emphysema
predomin
chronic
bronchiti
frequent
exacerb
molecular
mechan
phenotyp
remain
larg
unknown
sever
studi
use
small
panel
select
biomark
suggest
inflamm
play
role
distinguish
phenotyp
although
primari
site
diseas
copd
lung
increas
evid
indic
copd
system
diseas
manifest
inflamm
weight
loss
skelet
muscl
dysfunct
sever
system
biomark
eg
serum
amyloid
procalcitonin
associ
exacerb
copd
furthermor
biomark
plasma
sputum
exhal
breath
also
associ
fatfre
mass
subject
mild
copd
system
natur
hypothes
genomewid
express
profil
peripher
blood
may
use
identifi
signatur
copd
phenotyp
genomewid
express
studi
subject
copd
emphysema
perform
lung
tissu
typic
involv
small
sampl
size
n
invas
sampl
collect
altern
propos
use
peripher
blood
studi
gene
express
profil
smoker
without
copd
noninvas
avail
eas
use
biomark
screen
util
peripher
blood
gene
express
profil
identif
molecular
signatur
demonstr
wide
rang
diseas
disord
includ
cancer
neurolog
diseas
furthermor
studi
copd
found
overlap
gene
express
signatur
blood
lung
tissu
alveolar
macrophag
howev
recent
copd
studi
blood
involv
small
sampl
size
n
therefor
low
statist
power
observ
real
differ
primarili
examin
subject
less
sever
copd
overcom
limit
describ
investig
knowledg
largest
use
gene
express
profil
n
blood
comprehens
represent
copd
sever
studi
review
approv
institut
review
board
nation
jewish
health
subject
particip
provid
written
inform
consent
part
copdgen
cohort
current
former
smoker
age
year
histori
smoke
least
packyear
selfidentifi
either
nonhispan
white
africanamerican
experienc
acut
exacerb
copd
least
day
subject
initi
divid
either
hypothesi
n
replicationtest
n
group
hypothesi
group
design
repres
copd
cohort
broad
rang
airflow
obstruct
balanc
respect
demograph
clinic
covari
tabl
valid
top
find
use
independ
platform
discuss
subject
hypothesi
group
randomli
select
confirm
group
addit
independ
replic
subject
see
figur
tabl
onlin
supplement
copd
defin
postbronchodil
airflow
obstruct
ratio
forc
expiratori
volum
second
fev
forc
expiratori
volum
fvc
less
subdivid
stage
base
global
initi
chronic
obstruct
lung
diseas
gold
guidelin
subject
fev
fvc
greater
equal
fev
percentag
less
postbronchodil
consid
gold
unclassifi
secondari
endpoint
includ
percent
emphysema
ga
trap
walk
distanc
pleas
see
onlin
supplement
detail
peripher
blood
drawn
bd
vacutain
cell
prepar
tube
becton
dickinson
franklin
lake
nj
process
within
minut
accord
manufactur
instruct
upon
centrifug
lymphocyt
mononuclear
cell
appear
distinct
band
isol
supernat
rna
isol
perform
use
qiagen
rneasi
rna
isol
spincolumn
kit
protocol
combin
fulli
autom
qiagen
qiacub
qiagen
valencia
ca
express
transcript
measur
use
affymetrix
human
genom
plu
gene
array
geo
access
number
gse
affymetrix
santa
clara
ca
qualiti
control
perform
data
filter
normal
see
onlin
supplement
probe
set
linear
model
fit
associ
gene
express
lung
function
control
age
sex
bodi
mass
index
parent
histori
copd
two
smoke
variabl
smoke
statu
packyear
afterward
statist
signific
slope
express
test
control
falsediscoveri
rate
fdr
gene
whose
express
level
associ
lung
function
investig
use
ipa
ingenu
system
redwood
citi
ca
overrepresent
signific
gene
within
pathway
assess
use
fisher
exact
test
fdr
control
base
upon
preliminari
result
gene
interest
select
valid
use
appli
biosystem
foster
citi
ca
open
array
platform
see
onlin
supplement
express
determin
fold
chang
compar
panel
five
control
gene
spearman
correl
coeffici
calcul
primari
clinic
endpoint
p
valu
control
fdr
combin
p
valu
calcul
platform
perform
use
stouffer
combin
p
valu
test
direct
upregul
downregul
demograph
subject
use
microarray
analysi
list
gold
stage
tabl
attempt
made
balanc
subject
age
sex
packyear
differ
gold
stage
includ
spectrum
emphysema
sever
clinic
phenotyp
associ
gold
stage
packyear
smoke
current
smoke
statu
microarray
data
normal
filter
see
onlin
supplement
separ
linear
model
remain
transcript
fit
postbronchodil
fev
percentag
categor
covari
gold
stagespecif
percentag
given
along
p
valu
base
x
test
associ
standard
deviat
provid
parenthes
continu
covari
gold
stagespecif
mean
given
along
p
valu
base
overal
ftest
equal
mean
fev
fvc
across
subject
total
number
transcript
whose
rel
abund
associ
fev
percentag
control
demograph
smoke
covari
total
number
transcript
whose
rel
abund
associ
fev
fvc
control
covari
intersect
involv
transcript
tabl
statist
signific
gene
gene
express
explain
almost
variat
fev
percentag
figur
covari
entir
clinic
gene
express
model
explain
variat
fev
percentag
preliminari
investig
reveal
gene
statist
signific
transcript
map
canon
pathway
tabl
thirti
statist
signific
gene
repres
would
expect
chanc
larg
fraction
relat
immun
inflammatori
respons
eg
calciuminduc
lymphocyt
apoptosi
cell
receptor
signal
role
macrophag
fibroblast
endotheli
cell
rheumatoid
arthriti
exampl
figur
show
role
nuclear
factor
activ
cell
nfat
regul
immun
respons
pathway
transcript
factor
nfat
upregul
subject
sever
copd
metabol
pathway
also
overrepres
list
eg
sphingolipid
metabol
quantit
rtpcr
strategi
use
confirm
replic
pbmc
gene
express
select
gene
tabl
candid
gene
select
preliminari
microarray
result
base
overal
signific
accord
figur
role
nuclear
factor
activ
tcell
nfat
regul
immun
respons
pathway
gene
color
found
statist
signific
analysi
forc
expiratori
volum
secondforc
expiratori
volum
red
repres
posit
slope
phenotyp
green
repres
neg
slope
phenotyp
node
may
repres
relat
molecul
doubl
line
indic
famili
molecul
gene
identifi
transcript
correl
phenotyp
p
valu
occurr
signific
pathway
relat
immun
system
sphingolipid
metabol
signal
multipl
signific
pathway
confirm
involv
random
subject
profil
microarray
studi
figur
anoth
independ
subject
use
microarray
experi
use
replic
test
cohort
tabl
twentysix
gene
profil
show
signific
correl
express
fev
fvc
complet
cohort
fdradjust
p
see
tabl
onlin
data
supplement
signific
result
fev
percentag
involv
subset
result
fev
fvc
therefor
fev
fvc
report
magnitud
adjust
p
valu
direct
effect
correl
similar
confirm
replic
cohort
gene
effect
smoke
express
examin
larger
microarray
studi
current
smoke
statu
predict
gene
express
individu
probe
set
microarray
howev
packyear
signific
one
probe
set
gene
tabl
final
select
gene
examin
signific
discov
base
result
platform
name
microarray
n
quantit
rtpcr
n
ie
replic
cohort
contain
origin
microarray
studi
tabl
list
top
candid
panel
fdr
mani
candid
gene
associ
airflow
obstruct
also
associ
secondari
clinic
phenotyp
fdr
twelv
correl
emphysema
correl
ga
trap
eight
correl
distanc
walk
tabl
none
candid
gene
associ
chronic
bronchiti
correl
consist
microarray
result
tabl
base
diseas
sever
name
posit
correl
emphysema
ga
trap
neg
correl
distanc
walk
fev
percentag
fev
fvc
vice
versa
eight
gene
produc
signific
correl
primari
secondari
phenotyp
figur
assess
predict
power
top
candid
gene
predict
diseas
statu
supervis
learn
algorithm
random
forest
use
construct
classifi
top
candid
gene
tabl
estim
error
rate
approxim
base
express
probe
set
gene
use
microarray
data
origin
subject
similar
analysi
perform
quantit
rtpcr
data
use
replic
subject
microarray
analysi
estim
error
rate
although
studi
larg
investig
pbmc
gene
express
copd
recent
studi
report
wholeblood
microarray
gene
express
experi
use
sentrix
human
beadchip
illumina
san
diego
ca
microarray
platform
test
subject
confirm
subject
gold
stage
metaanalysi
result
identifi
signific
overlap
gene
p
see
onlin
supplement
explor
specif
find
copd
examin
three
pbmc
express
studi
chronic
inflammatori
diseas
unrel
lung
crohn
diseas
ulcer
coliti
acut
inflammatori
diseas
lung
sever
acut
respiratori
syndrom
studi
probe
set
filter
present
similar
evid
number
probe
set
filter
result
compar
three
studi
p
compar
retain
probe
set
signific
overlap
found
gene
list
differenti
express
gene
diseas
control
subject
three
studi
p
indic
identifi
pbmc
express
profil
specif
copd
sole
attribut
gener
diseas
state
metabolom
also
use
identifi
differ
smallmolecul
profil
among
patient
see
onlin
supplement
metabolom
investig
identifi
differenti
express
metabolit
control
subject
copd
search
metlin
databas
result
six
match
within
accept
mass
toler
ppm
one
lactosylceramid
also
known
galabiosylceramid
confirm
use
highperform
liquid
chromatographi
time
flight
figur
lactosylceramid
present
patient
emphysema
smoke
control
subject
none
patient
copd
emphysema
p
knowledg
one
largest
studi
microarray
gene
express
profil
copd
human
unlik
pbmc
microarray
public
abl
confirm
mani
signific
find
use
larg
independ
cohort
subject
candid
gene
report
associ
smaller
previous
publish
studi
pbmc
gene
express
similar
cohort
lend
weight
import
express
gene
biomark
copd
addit
larg
size
discoveri
test
cohort
studi
contain
addit
uniqu
featur
includ
highli
phenotyp
studi
popul
quantit
comput
tomographi
scan
balanc
studi
design
among
gold
group
companion
metabolom
investig
previou
studi
gene
express
subject
copd
use
either
lung
tissu
bronchial
epithelia
previou
studi
suggest
copd
system
diseas
postul
presenc
system
gene
express
profil
subject
copd
choic
studi
gene
express
pbmc
versu
lungspecif
cell
airway
epithelium
primarili
determin
access
suitabl
sampl
appropri
blood
draw
versu
bronchoscopi
clinic
assay
microarray
pbmc
use
identifi
gene
signatur
diseas
divers
exert
heat
injuri
sepsi
multipl
sclerosi
pbmc
use
discrimin
subject
healthi
lung
lung
diseas
figur
box
plot
express
foldchang
base
quantit
rtpcr
complet
cohort
across
global
initi
chronic
obstruct
lung
diseas
statu
box
plot
separ
panel
outlier
display
top
line
segment
box
plot
first
quartil
box
segment
line
second
quartil
horizont
line
within
box
repres
median
box
segment
median
third
quartil
line
segment
box
fourth
quartil
point
outsid
dash
line
outlier
box
distanc
third
quartil
chronic
beryllium
diseas
lung
cancer
pulmonari
hypertens
well
distinguish
diseas
activ
among
patient
sever
asthma
lung
cancer
sicklecel
diseas
copd
pbmc
microarray
approach
use
previous
small
discoveri
studi
pbmc
research
subject
subject
undergo
resect
lung
tumor
well
wholeblood
leukocyt
contain
predominantli
neutrophil
train
research
subject
cohort
limit
small
sampl
size
well
lack
comprehens
phenotyp
eg
emphysema
accord
highresolut
comput
tomographi
howev
studi
show
promis
use
pbmc
gene
express
biomark
copd
major
limit
human
gene
express
studi
copd
common
human
studi
inabl
determin
whether
differ
gene
express
caus
correl
howev
one
candid
gene
also
abl
use
metabolom
approach
identifi
relat
metabolit
lactosylceramid
biomark
copd
emphysema
major
analyt
strategi
interpret
hundr
statist
signific
differ
gene
express
involv
pathway
analysi
analysi
suggest
subject
copd
like
exhibit
differ
transcript
control
eukaryot
initi
factor
mechanist
target
rapamycin
gprotein
signal
mediat
tubbi
nfat
see
exampl
figur
tcell
activ
signal
helper
cell
cytotox
lymphocyteassoci
protein
signal
cytotox
lymphocyt
oxid
stress
signal
reactiv
oxygen
speci
metabol
pathway
sphingolipid
metabol
signal
abund
differenti
express
immun
inflammatori
respons
gene
unexpect
consid
pbmc
profil
although
candid
pathway
inform
number
gene
pathway
prohibit
replic
quantit
rtpcr
strategi
thu
strategi
replic
studi
includ
select
gene
base
varieti
criteria
includ
highli
signific
repres
pathway
interest
highlight
candid
gene
signific
valid
studi
discuss
encod
enzym
nacylsphingosin
amidohydrolas
acid
ceramidas
catalyz
degrad
ceramid
sphingosin
fatti
acid
associ
lysosom
storag
disord
farber
diseas
highli
express
thyroid
lymphocyt
lung
accord
gene
atla
knockdown
rat
alveolar
macrophag
improv
cigarett
smokeinduc
inhibit
apoptosi
recent
wholeblood
microarray
studi
use
train
test
subject
wholeblood
express
top
candid
biomark
distinguish
subject
without
airflow
obstruct
fev
fvc
versu
fev
fvc
respect
studi
express
pbmc
higher
subject
sever
copd
emphysema
train
test
cohort
evid
pathway
import
emphysema
copd
metabolom
investig
identifi
glycoceramid
galabiosylceramid
biomark
emphysema
interestingli
abnorm
accumul
galabiosylceramid
occur
fabri
syndrom
angiokeratoma
corpori
diffusum
patient
fabri
syndrom
prone
manifest
copd
emphysema
ceramid
bioactiv
lipid
mediat
cell
prolifer
differenti
apoptosi
adhes
migrat
ceramidas
acid
ceramidas
catalyz
hydrolysi
ceramid
sphingosin
thu
acid
ceramid
play
role
metabol
ceramid
galabiosyceramid
believ
first
report
identifi
galabiosylceramid
biomark
copd
howev
addit
work
need
understand
role
glycoceramid
pathogenesi
emphysema
forkhead
box
encod
transcript
factor
express
lung
import
lung
develop
protein
shown
act
cooper
histon
deacetylas
regul
express
modul
lung
epitheli
injuri
respons
studi
found
also
express
pbmc
lower
express
associ
airflow
obstruct
emphysema
low
level
express
also
report
associ
copd
pbmc
subject
undergo
resect
lung
cancer
shown
play
role
integrindepend
modul
gene
express
macrophag
differenti
thu
whether
gene
express
function
lymphocyt
marker
gene
express
lung
remain
unclear
tolllik
receptor
recogn
singlestrand
viral
rna
associ
asthma
allerg
rhiniti
found
pbmc
express
significantli
lower
concentr
subject
copd
lower
express
patient
copd
could
result
increas
suscept
viral
infect
vanin
code
pantethein
hydrolas
express
tissu
demonstr
high
express
leukocyt
observ
subject
copd
demonstr
lower
express
pbmc
associ
express
whole
blood
copd
also
found
cohort
describ
edmiston
colleagu
mechan
vanin
might
caus
copd
unknown
howev
vanin
formerli
call
shown
play
role
leukocyt
traffick
express
alveolar
macrophag
major
limit
studi
crosssect
basi
limit
may
assum
minor
import
biolog
variabl
microarray
gene
express
low
short
time
period
wk
suggest
stabil
gene
express
phenotyp
howev
stabil
pbmc
gene
express
longer
time
period
unknown
know
whether
gene
express
profil
predict
declin
lung
function
progress
emphysema
furthermor
parent
copdgen
studi
smoker
normal
spirometri
defin
control
subject
base
control
subject
abl
assess
effect
smoke
alon
pbmc
express
other
report
gene
express
associ
smoke
oxid
stress
respons
antiapoptosi
celldeath
signal
carcinogen
metabol
howev
found
final
candid
gene
correl
smoke
variabl
express
either
nonexist
rel
small
compar
effect
covari
sever
studi
profil
lung
tissu
copd
emphysema
subject
find
signific
overlap
pbmc
gene
identifi
present
work
previou
studi
data
shown
result
suggest
common
signatur
pbmc
lung
tissu
comparison
also
base
small
sampl
size
n
compromis
statist
power
futur
work
larger
studi
pair
analys
blood
lung
tissu
subject
abl
provid
definit
conclus
final
cost
statist
power
express
profil
restrict
one
racial
ethnic
group
nonhispan
white
although
larg
studi
independ
replic
cohort
addit
gene
express
studi
neversmok
ethnic
race
differ
clinic
research
studi
would
improv
generaliz
find
despit
limit
use
copdgen
abl
leverag
larg
wellphenotyp
cohort
subject
copd
candid
gene
identifi
studi
suggest
new
diseas
target
mechanist
studi
design
identifi
candid
gene
might
import
caus
copd
conclus
studi
knowledg
largest
gene
express
studi
smoker
copd
demonstr
potenti
pbmc
gene
express
serv
biomark
copd
express
candid
gene
confirm
two
independ
group
two
differ
assay
sever
candid
suggest
novel
potenti
target
pathway
signal
verifi
plasma
metabolom
approach
author
disclosur
avail
text
articl
wwwatsjournalsorg
